McKinsey and Company will pay $650 million over work it did for Purdue Pharma that federal prosecutors say helped fuel the opioid crisis. The settlement resolves criminal and civil Justice Department investigations into McKinsey's work helping Purdue increase sales of powerful opioids despite concerns about addiction.
